StockNews.com began coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Friday morning. The firm issued a sell rating on the stock. Separately, D.

It was a wonder to see the sage, Nigerian Nobel laureate, Professor Wole Soyinka man the stage at the 6th ProvidusBank World Poetry Day Café, held on March 21 at Terra Kulture Arena in Lagos. The ...

Governor Brad Little has signed a new media shield law, making Idaho the 41st state to enact such legislation. The law, which ...

VolitionRX VNRX is preparing to release its quarterly earnings on Monday, 2025-03-31. Here's a brief overview of what ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European ...

Spring has sprung and so have a list of interesting startups that raised cash. In March, that includes a startup focused on robotic massages, one helping people with pets find rentals, and some health ...